blog
The Altascientist
THE ALTASCIENTIST, ISSUE NO. 8
Facing bioanalytical challenges when evaluating the immunogenicity profile of protein-based therapeutic drugs
SELECT A CATEGORY BELOW
BLOG
-
Blog
Because who Doesn’t Love a Quiz!
There is a lot (A LOT) of information on the internet about clinical trials. What exactly are clinical trials? What are the different phases? What does each phase test? How safe are they? An...
-
Blog
Are Biosimilars Destined to Replace Biologics?
Starting with insulin over six decades ago, biologics have become the fastest-growing class of therapeutic compounds. They have provided treatment options for people who suffer from some of the mos...
-
Blog
7 TIPS TO SURVIVE THE HOLIDAY MADNESS
The holiday season is upon us once again! It’s a happy and exciting period for some, but can also be a stressful and borderline anxiety-inducing time for others. Dinners, parties, spen...
-
Blog
February 23 — On this Day in History
Welcome to a “This Day in History” edition of our blog! Every evening, since I was just a kid, I have tuned in to watch Jeop...
-
Blog
Thinking of Participating in Multiple Studies at Once?
According to Verified Clinical Trials (VCT), a worldwide clinical trials database registry to prevent dual enrollment...
-
Blog
What Effect Will the New NIH Policy Have On Multi-Site Research?
In June 2016, the National Institutes of Health (NIH) released a new policy on the use of a single i...
-
Blog
What Does it Take? | Biologic and Biosimilar Clinical Trials
It’s the much-anticipated Part II of our “What Does it Take” series (insert glorious trumpet announcement sound here). In Part I, we discussed general First-In-Human (FIH) clinical trials, and...